Hogan Lovells, Life Sciences | Chambers Asia-Pacific Profile

About

Provided by Hogan Lovells

We have been supporting clients in Asia-Pacific for over three decades and we are backed by a global dedicated life sciences practice comprising 500 lawyers around the world. Leveraging the full-service capabilities of our offices within the region, we can offer a dedicated team of culturally-attuned, multi-jurisdictional and multi-practice lawyers with substantial experience and background life sciences and health care and the ability to advise on the full scope of issues in this sector.

We understand how to bridge the gap between the challenges you face and the outcome you want. Our team is prepared to assist you with all of your needs, including:

Antitrust
Capital Markets
Clinical trials
Commercial contracts
Dispute resolution, including litigation and international arbitration
Fraud, abuse and compliance
Innovation and technology transfer
Intellectual Property
Partnerships, strategic alliances and collaboration
Pharma and medical device regulatory issues
Privacy and Cybersecurity
Product liability
Mergers and acquisitions, joint ventures and restructuring
Supply chains
Telehealth services

Chambers Review

Provided by Chambers

Life Sciences - Asia-Pacific Region

Band 1

What the Team is Known For

Hogan Lovells has a respected Asia-wide practice with an established presence in China and Japan. The team is capable of advising companies across the spectrum of life sciences issues, with expertise in the fields of commercial agreements, product liability, disputes, investigations and compliance. Hogan Lovells is known for its work on IP protection and enforcement, cross-border transactions and FDI matters and handles work for a strong roster of leading global pharmaceutical, medical device and biotech companies. The firm also boasts capable corporate M&A expertise to bolster its life sciences offering.

Notable practitioners

Tokyo-based Frederick Ch'en is a main contact for the firm's Japan life sciences practice and Zhou Lu and Calvin Ding are key contacts in China.

View ranking table

Work Highlights

Hogan Lovells International advised Shimadzu Corporation on its investments in Sepragen Corporation and U-Medico.

Strengths

Provided by Chambers

They advise not only from a legal point of view, but also from a pharmaceutical and biotech perspective. They are strong in cases that are particularly complex and require scientific understanding.

Life Sciences respondent
Asia-Pacific

They advise not only from a legal point of view, but also from a pharmaceutical and biotech perspective. They are strong in cases that are particularly complex and require scientific understanding.

Life Sciences respondent
Asia-Pacific